U.S., April 9 -- ClinicalTrials.gov registry received information related to the study (NCT06916156) titled 'Evaluation of the Concentration of ANT3310 and Meropenem in the Lung in Healthy Adult Participants' on April 02.
Brief Summary: This is an open-label, non-randomized, single-center, repeated i.v. doses, Phase 1 trial to evaluate the pharmacokinetics, safety, and tolerability of a combination of MEM-ANT3310 in healthy adult female and male participants who will undergo a single bronchoalveolar lavage (BAL) via a standardized fiberoptic bronchoscopy to evaluate and compare the pharmacokinetics characteristics of ANT3310 and meropenem (MEM) in plasma and epithelial lining luid (ELF).
Study Start Date: April 28
Study Type: INTERVENTIO...